Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4 instead of v3.3.3; this update does not change any study details, eligibility, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T01:50:42.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Type 2 diabetes as a topic and MedlinePlus Genetics as a related topic to the page.
    Difference
    0.2%
    Check dated 2026-01-07T00:55:26.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Type 2 diabetes is no longer listed as a condition on the page, and the MedlinePlus Genetics related topics section has been removed.
    Difference
    0.2%
    Check dated 2025-12-30T19:49:23.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added the Locations section with the Gyeonggi-do site (Seongnam-si, South Korea) and updated the revision to v3.3.3. Removed the Gyeonggi-do Locations header and the HHS Vulnerability Disclosure link in this update.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:11.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page shows an updated revision note (Revision: v3.3.2) and the previous revision (Revision: v3.2.0) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:53:24.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Removed the government funding notice banner that warned about potential delays and updates.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:34.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.